Physician profile
John Howard Payne
NPI 1922109958
$1,069.72
in general payments reported to CMS, 2019-2025
11 companies · $329 in 2025
The $329 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2021: $69.74 · 2022: $232 · 2023: $200 · 2024: $93.72 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $622.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $725.24 | 2019-2025 | Puraply, Puraply Wound Matrix, Affinity |
| Kci USA, INC. | $89.08 | 2019-2022 | |
| Convatec INC. | $52.90 | 2023-2025 | |
| Mimedx Group, INC. | $50.84 | 2025 | |
| Integra Lifesciences Corporation | $43.24 | 2021-2024 | Tcc-Ez |
| Paratek Pharmaceuticals, INC. | $27.90 | 2024-2025 | Nuzyra |
| Tei Medical INC. | $17.60 | 2019 | |
| Kerecis Limited | $16.90 | 2019 | |
| Amniox Medical, INC. | $16.90 | 2019 | |
| Reprise Biomedical, INC. | $16.35 | 2025 | Miro 3d |
| Tactile Systems Technology INC | $12.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Payne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.